I believe that's correct. The fluctuations are really based on Genome's cashflow requirements. Specifically, in budget 2008 there was a minus $0.2 million drop; in budget 2010 there was a $7.3 million positive increase; and then in budget 2012 there was a drop of $15 million, which I think gives you the number you quoted.
On May 26th, 2015. See this statement in context.